Arda Therapeutics Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
21
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$43.3M
- Investors
-
20
Arda Therapeutics General Information
Description
Developer of transformative therapeutics designed to remove pathological cells, which are the root causes of chronic diseases. The company uses single-cell data from patients to identify which cells to target and how to target them, and then designs therapeutics to remove the entire pathological network, that is, the entire cell, enabling patients to get cured without affecting any cell other than their pathological cells.
Contact Information
Website
www.ardatx.comCorporate Office
- 1030 Brittan Avenue
- San Carlos, CA 94070
- United States
Corporate Office
- 1030 Brittan Avenue
- San Carlos, CA 94070
- United States
Arda Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC (Series A) | 01-Oct-2024 | $43.3M | Completed | Generating Revenue | ||
| 1. Seed Round | 14-Jan-2022 | Completed | Generating Revenue |
Arda Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | ||||||||
| Seed |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Arda Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Arda Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Arda Therapeutics Investors (20)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Age 1 | Venture Capital | Minority | ||
| Alumni Ventures | Venture Capital | Minority | ||
| Biovision Ventures | Venture Capital | Minority | ||
| Deviation Capital | Venture Capital | Minority | ||
| Exitfund | Venture Capital | Minority |
Arda Therapeutics FAQs
-
When was Arda Therapeutics founded?
Arda Therapeutics was founded in 2021.
-
Where is Arda Therapeutics headquartered?
Arda Therapeutics is headquartered in San Carlos, CA.
-
What is the size of Arda Therapeutics?
Arda Therapeutics has 21 total employees.
-
What industry is Arda Therapeutics in?
Arda Therapeutics’s primary industry is Biotechnology.
-
Is Arda Therapeutics a private or public company?
Arda Therapeutics is a Private company.
-
What is the current valuation of Arda Therapeutics?
The current valuation of Arda Therapeutics is .
-
What is Arda Therapeutics’s current revenue?
The current revenue for Arda Therapeutics is .
-
How much funding has Arda Therapeutics raised over time?
Arda Therapeutics has raised $50.8M.
-
Who are Arda Therapeutics’s investors?
Age 1, Alumni Ventures, Biovision Ventures, Deviation Capital, and Exitfund are 5 of 20 investors who have invested in Arda Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
